DNA from cancer cells circulates in the blood from most subjects with cancer. This Circulating Tumor DNA (CT-DNA) harbors gene variants that cause the tumor. Cancer can therefore be detected and characterized with a CT-DNA test (also referred to as liquid biopsy).
This test is important for a patient-specific cancer treatment (personalized medicine) in patients diagnosed with cancer.
The CT-DNA test can also detect cancer in an early stage, and is therefore a good screening test in individuals with an increased risk to develop cancer.
The CT-DNA test offered by GENDIA screens for +/- 2800 common gene variants in 50 cancer genes.
The sample needed is 5 µg DNA or 5 ml EDTA blood to be sent at room temperature.